-+ 0.00%
-+ 0.00%
-+ 0.00%

Mercy BioAnalytics Receives FDA Approval to Initiate Prospective Pivotal Study of Evident™Ovarian Cancer Screening Test

Barchart·09/21/2026 12:27:00
語音播報

IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis ("SOARA") Clinical Validation Study following Institutional Review Board approval

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.